UBS Group
COCHW icon

UBS Group’s Envoy Medical Warrant COCHW Stock Holding History

UBS Group’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.12K Buy
+66,163
New +$2.58K ﹤0.01% 10078
2025
Q4 		– Sell
-482
Closed -$18 – 10583
2025
Q3 		$18 Buy
+482
New +$21 ﹤0.01% 10141
2024
Q3 		– Sell
-46
Closed -$2 – 9560
2024
Q2 		$2 Sell
46
-2,130
-98% -$233 ﹤0.01% 9419
2024
Q1 		$231 Sell
2,176
-1,939
-47% -$130 ﹤0.01% 8703
2023
Q4 		$82 Buy
+4,115
New +$111 ﹤0.01% 8949
2023
Q2 		– Sell
-600
Closed -$19 – 9008
2023
Q1 		$19 Buy
600
+193
+47% +$11 ﹤0.01% 9427
2022
Q4 		$16 Sell
407
-1,300
-76% -$62 ﹤0.01% 10565
2022
Q3 		$0 Hold
1,707
– – ﹤0.01% 10406
2022
Q2 		$0 Hold
1,707
– – ﹤0.01% 10383
2022
Q1 		$0 Hold
1,707
– – ﹤0.01% 10325
2021
Q4 		$1K Buy
+1,707
New +$1.25K ﹤0.01% 9960
2021
Q3 		– Sell
-2,101
Closed -$2K – 9599
2021
Q2 		$2K Buy
+2,101
New +$1.5K ﹤0.01% 8933

Other funds holding COCHW

AC
Athos Capital Hong Kong $175M AUM 18.68% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Sculptor Capital
Sculptor Capital New York $10.4B AUM 27.51% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4B AUM 28.69% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $165M AUM 14.14% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $33.5B AUM 25.57% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $14.8M AUM 14.32% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Marathon Trading Investment Management
Marathon Trading Investment Management Radnor, Pennsylvania $3.68B AUM 18.76% 1-Year Est. Return

UBS Group's COCHW Position: Q3 2026 in Review

UBS Group opened a new position in Envoy Medical Warrant (COCHW) in Q3 2026: 66,163 shares worth $2.12K. The stake represents ﹤0.01% of the portfolio and ranks #10078 among its holdings. This is a return to the name: UBS Group previously reported a position in COCHW as recently as Q3 2025.

UBS Group first reported a position in COCHW in Q2 2021 and has held it in 12 quarters since. 16 funds tracked by Wall St. Rank hold COCHW as of Q3 2026.

  • UBS Group held 66,163 shares of Envoy Medical Warrant worth $2.12K as of Q3 2026.
  • Envoy Medical Warrant was a new UBS Group position in Q3 2026.
  • Envoy Medical Warrant made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10078 holding.
  • UBS Group first reported a position in Envoy Medical Warrant in Q2 2021 and has held it in 12 quarters since.
  • 16 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.